A Toronto, Canada venture dedicated to digital wound care announced a digital imaging platform launching to support the industry’s move to decentralized, remote clinical trials.…
A Chinese biopharma venture founded in 2017 just snatched up a Canadian biotech developing an mRNA COVID-19 vaccine to bring more effective vaccine technology to…
Two small specialty biotech ventures merged as AzurRx BioPharma Inc. (AzurRx) traded on Nasdaq as “AZRX”, a company specializing in the development of targeted, non-systemic…
A San Francisco Bay Area biotech firm just raised $195 million to develop next-generation CRISPR products, pursuing their mission to cure and detect diseases. With…
Although the data from clinical trials are ongoing, the Pfizer-BioNTech team is busy working to plan the launch of their mRNA-based vaccine for SARS-CoV-2 for…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
